HeartSciences Inc. Deferred Income Tax Expense (Benefit)
HeartSciences Inc. (HSCS) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-07-23
- HeartSciences Inc. deferred income tax expense (benefit) for fiscal 2026 was $0.00.
- HeartSciences Inc. deferred income tax expense (benefit) for fiscal 2025 was $0.00.
| Period end | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|
| 2026-04-30 | $0.00 10-K · filed 2026-07-23 |
| 2025-04-30 | $0.00 10-K · filed 2026-07-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarkHorse Technologies Inc. (ANY) | $0.025B | ||
| Binah Capital Group, Inc. (BCG) | United States | $0.020B | 6.21 |
| Pineapple Financial Inc. (PAPL) | Canada | $0.026B | |
| AIxCrypto Holdings, Inc. (AIXC) | United States | $0.029B | -1.02 |
| AtlasClear Holdings, Inc. (ATCH) | United States | $0.030B | |
| MDB Capital Holdings, LLC (MDBH) | United States | $0.016B | |
| Fold Holdings, Inc. (FLD) | United States | $0.030B | |
| VerifyMe, Inc. (VRME) | United States | $0.015B | -1.55 |
| House of Doge Inc. (HODO) | United States | $0.015B | |
| TAO Synergies Inc. (TAOX) | United States | $0.033B |